Fusion Pharmaceuticals In... (FUSN)

The total Delta Exposure (DEX) for FUSN across all expirations shows 21.52 net shares that market makers must hedge, with 21.52 from calls and 0 from puts. The put-call delta ratio of 0.00 shows bullish positioning with call dominance, potentially providing upward momentum but leaving the market vulnerable to sharp pullbacks. The largest delta concentration at Feb 20, 26 with 21.52 net DEX represents significant hedging pressure that may cap upside moves. The nearest expiration on Jan 16, 26 carries negative delta forcing market makers to buy shares, potentially providing support.